1887

Journal of Medical Microbiology logo

Volume 59, Issue 11

Serological diagnosis of infection: limitations and perspectives Free

Abstract

is an obligate intracellular human pathogen responsible for a wide range of acute and chronic human diseases, including pneumonia and other respiratory diseases. Serological methods for the diagnosis of infection vary widely, and several authors have reported significant inter- and intra-laboratory variability in diagnostic methods and criteria. Over the past 10 years, numerous studies have focused on the identification of specific antigens for application in serodiagnosis, including the diagnosis of persistent infections. The use of proteomics may enable the development of serological diagnosis kits that offer reliable sensitivity and specificity and might even differentiate between the various stages of infection with this pathogen.

  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.020362-0
2010-11-01
2024-05-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/11/1267.html?itemId=/content/journal/jmm/10.1099/jmm.0.020362-0&mimeType=html&fmt=ahah

References

  1. Apfalter P. 2006; Chlamydia pneumoniae , stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again?. Stroke 37:756–758 [CrossRef]
     [Google Scholar]
  2. Bas S., Muzzin P., Vischer T. L. 2001; Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens. J Clin Microbiol 39:4082–4085 [CrossRef]
     [Google Scholar]
  3. Bergmann S., Rohde M., Chhatwal G. S., Hammerschmidt S. 2001; α -Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Mol Microbiol 40:1273–1287 [CrossRef]
     [Google Scholar]
  4. Black C. M., Fields P. I., Messmer T. O., Berdal B. P. 1994; Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers. Eur J Clin Microbiol Infect Dis 13:752–756 [CrossRef]
     [Google Scholar]
  5. Blasi F., Legnani D., Lombardo V. M., Negretto G. G., Magliano E., Pozzoli R., Chiodo F., Fasoli A., Allegra L. 1993; Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 6:19–22
     [Google Scholar]
  6. Boman J., Hammerschlag M. R. 2002; Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15:1–20 [CrossRef]
     [Google Scholar]
  7. Boman J., Allard A., Persson K., Lundborg M., Juto P., Wadell G. 1997; Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. J Infect Dis 175:1523–1526 [CrossRef]
     [Google Scholar]
  8. Bourke S. J., Carrington D., Frew C. E., Stevenson R. D., Banham S. W. 1989; Serological cross-reactivity among chlamydial strains in a family outbreak of psittacosis. J Infect 19:41–45 [CrossRef]
     [Google Scholar]
  9. Bunk S., Susnea I., Rupp J., Summersgill J. T., Maass M., Stegmann W., Schrattenholz A., Wendel A., Przybylski M., Hermann C. 2008; Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent Chlamydia pneumoniae infections. J Immunol 180:5490–5498 [CrossRef]
     [Google Scholar]
  10. Byrne G. I., Ouellette S. P., Wang Z., Rao J. P., Lu L., Beatty W. L., Huson A. P. 2001; Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun 69:5423–5429 [CrossRef]
     [Google Scholar]
  11. Campbell L. A., Kuo C. C. 2004; Chlamydia pneumoniae – an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2:23–32 [CrossRef]
     [Google Scholar]
  12. Campbell L. A., Roberts S., Inoue S., Kong L., Kuo C. C. 2001; Evaluation of Chlamydia pneumoniae 43- and 53-kilodalton recombinant proteins for serodiagnosis by Western blot. Clin Diagn Lab Immunol 8:1231–1233
     [Google Scholar]
  13. Chirgwin K., Roblin P. M., Gelling M., Hammerschlag M. R., Schachter J. 1991; Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 163:757–761 [CrossRef]
     [Google Scholar]
  14. Christiansen G., Pedersen A. S., Hjernø K., Vandahl B., Birkelund S. 2000; Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine. J Infect Dis 181:S528–S537 [CrossRef]
     [Google Scholar]
  15. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Wong Y., Bernardes-Silva M., Ward M. 2000; Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321:208–213 [CrossRef]
     [Google Scholar]
  16. Danesh J., Whincup P., Lewington S., Walker M., Lennon L., Thomson A., Wong Y. K., Zhou X., Ward M. 2002; Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J 23:371–375 [CrossRef]
     [Google Scholar]
  17. Dowell S. F., Peeling R. W., Boman J., Carlone G. M., Fields B. S., Guarner J., Hammerschlag M. R., Jackson L. A., Kuo C. C. other authors 2001; Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada. Clin Infect Dis 33:492–503 [CrossRef]
     [Google Scholar]
  18. Emre U., Roblin P. M., Gelling M., Dumornay W., Rao M., Hammerschlag M. R. 1994; The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 148:727–732 [CrossRef]
     [Google Scholar]
  19. Finco O., Bonci A., Agnusdei M., Scarselli M., Petracca R., Norais N., Ferrari G., Garaguso I., Donati M. other authors 2005; Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine 23:1178–1188 [CrossRef]
     [Google Scholar]
  20. Gaydos C. A., Eiden J. J., Oldach D., Mundy L. M., Auwaerter P., Warner M. L., Vance E., Burton A. A., Quinn T. 1994a; Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis 19:157–160 [CrossRef]
     [Google Scholar]
  21. Gaydos C. A., Roblin P. M., Hammerschlag M. R., Hyman C. L., Eiden J. J., Schachter J., Quinn T. C. 1994b; Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 32:903–905
     [Google Scholar]
  22. Gnarpe J., Nääs J., Lundbäck A. 2000; Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae . APMIS 108:819–824 [CrossRef]
     [Google Scholar]
  23. Grayston J. T. 2000; Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181:S402–S410 [CrossRef]
     [Google Scholar]
  24. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C., Saikku P., Thom D., Wang S. P. 1990; A new respiratory tract pathogen: Chlamydia pneumoniae , strain TWAR. J Infect Dis 161:618–625 [CrossRef]
     [Google Scholar]
  25. Grayston J. T., Kuo C. C., Coulson A. S., Campbell L. A., Lawrence R. D., Lee M. J. 1995; Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92:3397–3400 [CrossRef]
     [Google Scholar]
  26. Gutiérrez J., Linares-Palomino J., Lopez-Espada C., Rodríguez M., Ros E., Piédrola G., del Maroto M. C. 2001; Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease. Infection 29:196–200 [CrossRef]
     [Google Scholar]
  27. Gutiérrez J., de Dios Luna J., Linares J., del Rosario Montes M., Quesada E., Rojas A., Soto M. J., Sorlozano A. 2005; Relationship between peripheral arterial occlusive disease (PAOD) and chronic Chlamydophila ( Chlamydia ) pneumoniae infection. A meta-analysis. Thromb Haemost 93:1153–1160
     [Google Scholar]
  28. Gutiérrez J., Linares J., Camacho A., Palanca M., Maroto C., Ros E., de Dios Luna J., Soto M. J., Sorlózano A. 2006; Description of immunogens of Chlamydia pneumoniae recognized by serum of individuals with peripheral artery disease. Med Clin (Barc 126:721–727 [CrossRef]
     [Google Scholar]
  29. Hahn D. L., McDonald R. 1998; Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?. Ann Allergy Asthma Immunol 81:339–344 [CrossRef]
     [Google Scholar]
  30. Halme S., Latvala J., Karttunen R., Palatsi I., Saikku P., Surcel H. M. 2000; Cell-mediated immune response during primary Chlamydia pneumoniae infection. Infect Immun 68:7156–7158 [CrossRef]
     [Google Scholar]
  31. Hammerschlag M. R. 2002; The intracellular life of chlamydiae. Semin Pediatr Infect Dis 13:239–248 [CrossRef]
     [Google Scholar]
  32. Hammerschlag M. R., Chirgwin K., Roblin P. M., Gelling M., Dumornay W., Mandel L., Smith P., Schachter J. 1992; Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 14:178–182 [CrossRef]
     [Google Scholar]
  33. Hermann C., Graf K., Groh A., Straube E., Hartung T. 2002; Comparison of eleven commercial tests for Chlamydia pneumoniae -specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 40:1603–1609 [CrossRef]
     [Google Scholar]
  34. Hermann C., Gueinzius K., Oehme A., von Aulock S., Straube E., Hartung T. 2004; Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol 42:2476–2479 [CrossRef]
     [Google Scholar]
  35. Hogan R. J., Mathews S. A., Mukhopadhyay S., Summersgill J. T., Timms P. 2004; Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72:1843–1855 [CrossRef]
     [Google Scholar]
  36. Hyman C. L., Augenbraun M. H., Roblin P. M., Schachter J., Hammerschlag M. R. 1991; Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J Clin Microbiol 29:2082–2083
     [Google Scholar]
  37. Hyman C. L., Roblin P. M., Gaydos C. A., Quinn T. C., Schachter J., Hammerschlag M. R. 1995; Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20:1174–1178 [CrossRef]
     [Google Scholar]
  38. Ieven M. M., Hoymans V. Y. 2005; Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 43:19–24 [CrossRef]
     [Google Scholar]
  39. Iijima Y., Miyashita N., Kishimoto T., Kanamoto Y., Soejima R., Matsumoto A. 1994; Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans. J Clin Microbiol 32:583–588
     [Google Scholar]
  40. Jantos C. A., Heck S., Roggendorf R., Sen-Gupta M., Hegemann J. H. 1997; Antigenic and molecular analyses of different Chlamydia pneumoniae strains. J Clin Microbiol 35:620–623
     [Google Scholar]
  41. Kalman S., Mitchell W., Marathe R., Lammel C., Fan J., Hyman R. W., Olinger L., Grimwood J., Davis R. W., Stephens R. S. 1999; Comparative genomes of Chlamydia pneumoniae and Chlamydia trachomatis . Nat Genet 21:385–389 [CrossRef]
     [Google Scholar]
  42. Kern D. G., Neill M. A., Schachter J. 1993; A serological study of Chlamydia pneumoniae in Rhode Island: evidence of serological cross-reactivity. Chest 104:208–213 [CrossRef]
     [Google Scholar]
  43. Klein M., Kötz A., Bernardo K., Krönke M. 2003; Detection of Chlamydia pneumoniae -specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein. J Clin Microbiol 41:1957–1962 [CrossRef]
     [Google Scholar]
  44. Knudsen K., Madsen A. S., Mygind P., Christiansen G., Birkelund S. 1999; Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae . Infect Immun 67:375–383
     [Google Scholar]
  45. Kubo A., Stephens R. S. 2000; Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing agent. Mol Microbiol 38:772–780 [CrossRef]
     [Google Scholar]
  46. Kutlin A., Roblin P. M., Hammerschlag M. R. 1998; Antibody response to Chlamydia pneumoniae infection in children with respiratory illness. J Infect Dis 177:720–724 [CrossRef]
     [Google Scholar]
  47. Laurila A. L., Von Hertzen L., Saikku P. 1997; Chlamydia pneumoniae and chronic lung diseases. Scand J Infect Dis Suppl 104:34–36
     [Google Scholar]
  48. Longbottom D., Psarrou E., Livingstone M., Vretou E. 2001; Diagnosis of ovine enzootic abortion using an indirect ELISA (rOMP91B iELISA) based on a recombinant protein fragment of the polymorphic outer membrane protein POMP91B of Chlamydophila abortus . FEMS Microbiol Lett 195:157–161 [CrossRef]
     [Google Scholar]
  49. Longbottom D., Fairley S., Chapman S., Psarrou E., Vretou E., Livingstone M. 2002; Serological diagnosis of ovine enzootic abortion by enzyme-linked immunosorbent assay with a recombinant protein fragment of the polymorphic outer membrane protein POMP90 of Chlamydophila abortus . J Clin Microbiol 40:4235–4243 [CrossRef]
     [Google Scholar]
  50. Mathews S., George C., Flegg C., Stenzel D., Timms P. 2001; Differential expression of ompA , ompB , pyk , nlpD and Cpn0585 genes between normal and interferon- γ treated cultures of Chlamydia pneumoniae . Microb Pathog 30:337–345 [CrossRef]
     [Google Scholar]
  51. Mehta S. J., Miller R. D., Ramirez J. A., Summersgill J. T. 1998; Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon- γ : role of tryptophan catabolism. J Infect Dis 177:1326–1331 [CrossRef]
     [Google Scholar]
  52. Melgosa M. P., Kuo C. C., Campbell L. A. 1993; Outer membrane complex proteins of Chlamydia pneumoniae . FEMS Microbiol Lett 112:199–204 [CrossRef]
     [Google Scholar]
  53. Molestina R. E., Klein J. B., Miller R. D., Pierce W. H., Ramirez J. A., Summersgill J. T. 2002; Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 70:2976–2981 [CrossRef]
     [Google Scholar]
  54. Montigiani S., Falugi F., Scarselli M., Finco O., Petracca R., Galli G., Mariani M., Manetti R., Agnusdei M. other authors 2002; Genomic approach for analysis of surface proteins in Chlamydia pneumoniae . Infect Immun 70:368–379 [CrossRef]
     [Google Scholar]
  55. Mukhopadhyay S., Millar R. D., Summersgill J. T. 2004; Analysis of altered protein expression patterns of Chlamydia pneumoniae by an integrated proteome-works system. J Proteome Res 3:878–883 [CrossRef]
     [Google Scholar]
  56. Mukhopadhyay S., Miller R. D., Sullivan E. D., Theodoropoulos C., Mathews S. A., Timms P., Summersgill J. T. 2006; Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun 74:3853–3863 [CrossRef]
     [Google Scholar]
  57. Mygind P., Christiansen G., Persson K., Birkelund S. 1998; Analysis of the humoral immune response to Chlamydia outer membrane protein 2. Clin Diagn Lab Immunol 5:313–318
     [Google Scholar]
  58. Ozanne G., Lefebvre J. 1992; Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. Can J Microbiol 38:1185–1189 [CrossRef]
     [Google Scholar]
  59. Pancholi V., Fischetti V. A. 1998; α -Enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273:14503–14515 [CrossRef]
     [Google Scholar]
  60. Pantoja L. G., Miller R. D., Ramirez J. A., Molestina R. E., Summersgill J. T. 2000; Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity. Infect Immun 68:6478–6481 [CrossRef]
     [Google Scholar]
  61. Park S. H., Kwon S. J., Lee S. J., Kim Y. C., Hwang K. Y., Kang Y. H., Lee K. J. 2009; Identification of immunogenic antigen candidate for Chlamydophila pneumoniae diagnosis. J Proteome Res 8:2933–2943 [CrossRef]
     [Google Scholar]
  62. Peeling R. W., Wang S. P., Grayston J. T., Blasi F., Boman J., Clad A., Freidank H., Gaydos C. A., Gnarpe J. other authors 2000; Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 181:S426–S429 [CrossRef]
     [Google Scholar]
  63. Penttilä J. M., Anttila M., Puolakkainen M., Laurila A., Varkila K., Sarvas M., Mäkelä P. H., Rautonen N. 1998; Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun 66:5113–5118
     [Google Scholar]
  64. Perez Melgosa M., Kuo C. C., Campbell L. A. 1994; Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope. Infect Immun 62:880–886
     [Google Scholar]
  65. Persson K., Boman J. 2000; Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae . Clin Diagn Lab Immunol 7:739–744
     [Google Scholar]
  66. Poquet I., Saint V., Seznec E., Simoes N., Bolotin A., Gruss A. 2000; HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. Mol Microbiol 35:1042–1051 [CrossRef]
     [Google Scholar]
  67. Read T. D., Brunham R. C., Shen C., Gill S. R., Heidelberg J. F., White O., Hickey E. K., Peterson J., Utterback T. other authors 2000; Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28:1397–1406 [CrossRef]
     [Google Scholar]
  68. Saikku P., Leinonen M., Mattila K., Ekman M. R., Nieminen M. S., Mäkelä P. H., Huttunen J. K., Valtonen V. 1988; Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983–986
     [Google Scholar]
  69. Stephens R. S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R. L. other authors 1998; Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis . Science 282:754–759 [CrossRef]
     [Google Scholar]
  70. Stephens R. S., Koshiyama K., Lewis E., Kubo A. 2001; Heparin-binding outer membrane protein of Chlamydiae . Mol Microbiol 40:691–699 [CrossRef]
     [Google Scholar]
  71. Strålin K., Fredlund H., Olcén P. 2001; Labsystems enzyme immunoassay for Chlamydia pneumoniae also detects Chlamydia psittaci infections. J Clin Microbiol 39:3425–3426 [CrossRef]
     [Google Scholar]
  72. Sueur J. M., Beaumont K., Cabioch T., Orfila J., Betsou F. 2006; Diagnostic value of an ELISA using a recombinant 54-kDa species-specific protein from Chlamydia pneumoniae . Clin Microbiol Infect 12:470–477 [CrossRef]
     [Google Scholar]
  73. Summersgill J. T., Sahney N. N., Gaydos C. A., Quinn T. C., Ramirez J. A. 1995; Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 63:2801–2803
     [Google Scholar]
  74. Vandahl B. B., Birkelund S., Demol H., Hoorelbeke B., Christiansen G., Vandekerckhove J., Gevaert K. 2001; Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 22:1204–1223 [CrossRef]
     [Google Scholar]
  75. Villegas E., Camacho A., Carrillo J. A., Sorlozano A., Rojas J., Gutiérrez J. 2008; Emerging strategies in the diagnosis, prevention and treatment of Chlamydophila pneumoniae infections. Expert Opin Ther Pat 18:1175–1189 [CrossRef]
     [Google Scholar]
  76. Wang S. P., Grayston J. T. 1998; Chlamydia pneumoniae (TWAR) micro-immunofluorescence antibody studies – 1998 update. In Chlamydial Infections pp 155–158 Edited by Stephens R. S., Byrne G. I., Christiansen G., Clarke I. N., Grayston J. T., Rank R. G., Ridgway G. L., Saikku P., Schachter J., Stamm W. E. Proceedings of the Ninth International Symposium on Human Chlamydial Infection San Francisco, CA:
     [Google Scholar]
  77. Watson M. W., Lambden P. R., Everson J. S., Clarke I. N. 1994; Immunoreactivity of the 60-kDa cysteine-rich proteins of Chlamydia trachomatis , Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli . Microbiology 140:2003–2011 [CrossRef]
     [Google Scholar]
  78. Wolf K., Fischer E., Mead D., Zhong G., Peeling R., Whitmire B., Caldwell H. D. 2001; Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun 69:3082–3091 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.020362-0
Loading
Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives
J. Med. Microbiol. 59, 1267 (2010); https://doi.org/10.1099/jmm.0.020362-0
/content/journal/jmm/10.1099/jmm.0.020362-0
/content/journal/jmm/10.1099/jmm.0.020362-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error